D. Scott Batty, Jr., M.D.

Chief Medical Officer

Dr. Batty brings more than 20 years of experience in the life sciences industry in medical affairs and clinical development leadership positions, including as CEO and as CMO at private and publicly held companies, and as a transplant surgeon.  Prior to joining Artax, Dr. Batty was VP of Regulatory and Scientific Affairs for CTI, Inc., a privately held contract research organization. Previous roles included Chief Medical Officer at Medeor Therapeutics, which developed an organ transplantation cell therapy platform to avoid the use of pharmacologic immunosuppression; Chief Executive Officer of ImmunArray Ltd., and Vice President of Global Medical Affairs for Genzyme Transplant and Oncology Group.  Dr. Batty was also a Global Director of Medical Affairs for the belatacept immunosuppression program while at Bristol-Myers Squibb.